United States
Germany
Japan
United Kingdom
China
Recombinant Anti-ICOSL (Clone HK5.3)
| Applications | Bl, FC |
| Reactivities | Mouse |
Products
Recombinant Anti-B7-H3 (Clone MJ18)
| Applications | Bl, FC |
| Reactivities | Mouse |
Recombinant Anti-CD154 (Clone YMF323.6)
| Applications | FC, WB |
| Reactivities | Human |
Anti-Beta Dystroglycan [P38G1], Rabbit IgG, kappa
| Applications | ELISA, FC |
| Reactivities | Human, Mouse |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Anti-CD4 [OX-38], Rabbit IgG, kappa
| Applications | FC, IP |
| Reactivities | Rat |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. |
Anti-BCMA [CA8], Rabbit IgG, kappa
| Applications | ELISA, FC |
| Reactivities | Human, Monkey |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Anti-TIGIT [4A5], Rabbit IgG, kappa
| Applications | ELISA, FC |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Anti-Cadherin 17 [D2111], Rabbit IgG, kappa
| Applications | ELISA, FC |
| Reactivities | Human |
| Modifications | This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. |
Recombinant Anti-CD63 (Clone MOF11)
| Applications | FC |
| Reactivities | Human |
Recombinant Anti-Ly6G (Clone 1A8)
| Applications | FC |
| Reactivities | Mouse |
Recombinant Anti-CD3 epsilon (Clone OKT-3 (muromonab))
| Applications | FC |
| Reactivities | Human |
Recombinant Anti-4-1BB (Clone LOB12.3)
| Applications | FC |
| Reactivities | Mouse |
Recombinant Anti-TIGIT (Clone 4D4)
| Applications | FC |
| Reactivities | Mouse |
Recombinant Anti-TIGIT (Clone 4D4)
| Applications | FC |
| Reactivities | Mouse |
Recombinant Anti-IL2R beta (Clone 5H4)
| Applications | FC |
| Reactivities | Mouse |
活动过滤器
优化搜索结果
Category
Target Symbol
- CD3E (7)
- CD4 (6)
- CD40 (5)
- CD40LG (5)
- EGFR (5)
- IL2RA (5)
- CD52 (4)
- IL9 (4)
- CD19 (3)
- CD27 (3)
- CD28 (3)
- CD37 (3)
- CD38 (3)
- CD74 (3)
- CD8A (3)
- TIGIT (3)
- AOC3 (2)
- BTLA (2)
- CCR5 (2)
- CCRL2 (2)
- CD274 (2)
- CD33 (2)
- CD44 (2)
- CD53 (2)
- CD63 (2)
- CD81 (2)
- CR1 (2)
- CTLA4 (2)
- EPCAM (2)
- ERBB2 (2)
- GPC3 (2)
- ITGB7 (2)
- LY6G (2)
- MS4A1 (2)
- MSLN (2)
- PTPRC (2)
- SELL (2)
- TAG72 (2)
- TIMD4 (2)
- TNFRSF14 (2)
- TNFRSF8 (2)
- TNFRSF9 (2)
- TNFSF18 (2)
- TNFSF9 (2)
- ABCB1 (1)
- ACKR1 (1)
- ADGRE1 (1)
- ADRB2 (1)
- AFP (1)
- AGER (1)
- BRD4 (1)
- C3AR1 (1)
- C5AR1 (1)
- CCR3 (1)
- CCR7 (1)
- CCR9 (1)
- CD15 (1)
- CD16 (1)
- CD16 (FCGR3A) (1)
- CD1A (1)
- CD2 (1)
- CD200R1 (1)
- CD22 (1)
- CD226 (1)
- CD276 (1)
- CD34 (1)
- CD59 (1)
- CD7 (1)
- CD70 (1)
- CD8 (1)
- CD80 (1)
- CD86 (1)
- CD8B1 (1)
- CDH1 (1)
- CDH17 (1)
- CEA (1)
- CENPE (1)
- CLEC4A (1)
- CLEC4M (1)
- CMKLR1 (1)
- CR2 (1)
- CSF1R (1)
- CXCR1 (1)
- CXCR2 (1)
- ENG (1)
- EPHA2 (1)
- FAS (1)
- FCAR (1)
- FCGR1A (1)
- FCGR2B (1)
- FOXP1 (1)
- FOXP2 (1)
- FOXP4 (1)
- G1 (1)
- GROUP ANTIGEN (1)
- HAVCR1 (1)
- HAVCR2 (1)
- HLA CLASS II (1)
- ICOSL (1)
- IFNG (1)
Reactivities
Antibody Hosts
Conjugates
Modifications
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG1 format for improved compatibility with existing reagents assays and techniques. (8)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG1 format for improved compatibility with existing reagents assays and techniques. (2)
- This chimeric rabbit antibody was made using the variable domain sequences of the original Mouse IgG2a format for improved compatibility with existing reagents assays and techniques. (2)
